PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23545481-6 2013 Estimated CLint for phthalic acid production by hCYP3A4 was 24.5 muL nmol CYP(-1)min(-1) while it was continuously produced by rCYP2C6 and 3A2 via passive mechanism. phthalic acid 20-33 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 48-55 27572875-4 2016 PXR agonists, phthalate and pregnenolone had significant positive effects on cytochrome P450 (CYP) 3A4 expression and PXR-mediated transcription through the CYP3A4 promoter, whereas MDR1 expression and PXR-mediated transcription though the MDR1 promoter were significantly increased in the presence of paclitaxel or cisplatin. phthalic acid 14-23 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 157-163 22186153-6 2012 Additionally, human CYP3A4 and rat CYP3A2 were the primary enzymes for PA production via heteroatom dealkylation of MEHP. phthalic acid 71-73 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 20-26 18332045-0 2008 Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression. phthalic acid 0-9 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 23-29 18332045-6 2008 We suggest that the magnitude of CYP3A4 induction by phthalates is dependent on the expression of PXR and may be significantly higher in the presence of glucocorticoids. phthalic acid 53-63 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 33-39 18332045-8 2008 Coexposure to phthalates and dexamethasone (Dex) resulted in enhanced CYP3A4 promoter activity; furthermore, this induction was abrogated by both the GR antagonist RU486 and GR small interfering ribonucleic acid. phthalic acid 14-24 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 70-76 18332045-11 2008 Finally, enhanced 6beta-hydroxytestosterone formation in Dex and phthalate cotreated human hepatocytes confirmed CYP3A4 enzyme induction. phthalic acid 65-74 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 113-119 18332045-12 2008 Concomitant exposure to glucocorticoids and phthalates resulting in enhanced metabolic activity of CYP3A4 may play a role in altered efficacy of pharmaceutical agents. phthalic acid 44-54 cytochrome P450 family 3 subfamily A member 4 Homo sapiens 99-105